Dr Xin Hui S Chan
Xin Hui Chan
BMBCh MA MSc MRCP DTM&H
Clinical Research Fellow
Big data for malaria elimination
Dr Xin Hui Chan is clinical research fellow in the Mahidol-Oxford Tropical Medicine Research Unit (MORU), specialty registrar in infectious diseases and general internal medicine at Oxford University Hospitals, and lecturer in medicine at Worcester College, University of Oxford. She is a member of the University of Oxford-MRC Doctoral Training Partnership and a recipient of the University of Oxford NDM Doctoral Prize Studentship.
Xin Hui is interested in translating scientific research into actionable interventions. Her current research focuses on optimising interventions for malaria elimination and containment of antimalarial resistance through evidence synthesis and clinical investigation. Her work combines drug safety / pharmacovigilance, pharmacoepidemiology, clinical pharmacology, and genomic epidemiology studies. She was the WHO technical resource person and rapporteur of the WHO Evidence Review Group on the Cardiotoxicity of Antimalarial Medicines.
Xin Hui's previous experience has been with the University of Oxford, the London School of Hygiene and Tropical Medicine, the MRC Unit in The Gambia, the US National Institutes of Health, and the UK Faculty of Medical Leadership and Management. She holds postgraduate qualifications in internal medicine, infectious diseases, and tropical medicine.
A Temporizing Solution to “Artemisinin Resistance”
(2019), New England Journal of Medicine, 381, 989 - 990
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study
Hamilton WL. et al, (2019), The Lancet Infectious Diseases, 19, 943 - 951
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial
von Seidlein L. et al, (2019), PLOS Medicine, 16, e1002745 - e1002745
The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
Haeusler IL. et al, (2018), BMC Medicine, 16
Risk of sudden unexplained death after use of dihydroartemisinin–piperaquine for malaria: a systematic review and Bayesian meta-analysis
Chan XHS. et al, (2018), The Lancet Infectious Diseases, 18, 913 - 923